SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-249331
Filing Date
2010-11-05
Accepted
2010-11-05 10:13:21
Documents
8
Period of Report
2010-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K d8k.htm 8-K 25358
2 FORM OF SUBSCRIPTION INVESTMENT UNIT dex41.htm EX-4.1 103467
3 FORM OF WARRANT dex42.htm EX-4.2 71423
4 AMENDMENT TO THE SECURITIES PURCHASE AGREEMENTS dex101.htm EX-10.1 16083
5 SECURITIES PURCHASE AGREEMENT dex102.htm EX-10.2 170405
6 CONSENT OF WOLF & COMPANY, P.C. dex231.htm EX-23.1 2089
7 PRESS RELEASE dex991.htm EX-99.1 7006
8 GRAPHIC g115591g60o23.jpg GRAPHIC 12546
  Complete submission text file 0001193125-10-249331.txt   414959
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 101167034
SIC: 2834 Pharmaceutical Preparations